Polibeli Group Ltd
PLBLPolibeli Group Ltd's balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is in a downtrend (5 weeks in). But the balance sheet is under water: net worth is negative, so shareholders sit behind everyone the company owes. What settles it: whether the business can earn its way back to positive equity before dilution or restructuring gets there first.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Polibeli Group Ltd trades at $6.0, in a downtrend and 5 weeks into that stage. That is −28.0% against its own 200-day average. It sits at 9% of a 52-week range of $5 to $12. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (2 weeks and counting).
Today the stock is in a downtrend — week 5 of stage 4. At $6.0 it trades −28.0% versus its 200-day average and sits at 9% of its 52-week range ($5–$12).
Against the market, two honest reads. Cumulative: over the last 2.0 years the stock moved −40% while the S&P 500 moved +45% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (2 weeks and counting; last ahead the week of 2026-07-24) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
P/E does not price Polibeli Group Ltd — earnings are negative, so there is no multiple to rank against its own history. The revenue and margin lines below are where a turn, when it comes, would show first. On sales the market values Polibeli Group Ltd at 66.7× its FY25 revenue of $0.0 B.
With earnings negative, P/E does not price — there is no multiple to rank against its own history. The revenue and margin lines below are where the turn, when it comes, will show first.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Polibeli Group Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
The return-on-capital curve is not shown — net worth is negative, so a return on capital is not a meaningful number in any basis. This is a distressed balance sheet, and the stage is read from the growth curves alone.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +0.0% | +0.0% | — | — |
| Stock price | −40.5% | — | — | — |
4-Factor Sector Score
34.6/100 — rank 4 of 4 in Department Stores · 33% evidence confidence · provisional, ranked below fully-evidenced peers
Polibeli Group Ltd scores 34.6 out of 100 against the 4 companies it is compared with in Department Stores, ranking 4. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 17.8 + 6.8 + 10 + 0 = 34.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Polibeli Group Ltd reported $0.0 B of revenue in the Dec 24 quarter, +100.0% year on year. Over 3 years it has compounded at 0.0% a year. The last full year, FY25, came in at $0.0 B. The last four reported quarters add to $0.1 B.
FY25 revenue came in at $0.0 B (+0.0% on the year), capping 3 years at 0.0% compound. The latest quarter (Dec 24) printed $0.0 B, +100.0% year on year.
Pace check: the last four quarters averaged +50.0% growth against the decade's 0.0% — the current year is running faster than its own long-run rate.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Polibeli Group Ltd's operating margin is 0.0% in the Dec 24 quarter, +0.0 percentage points against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged −50.0% to −33.3%. The current quarter is running above every full year in that window.
The latest quarter's operating margin is 0.0%, +0.0 pp against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged −50.0%–−33.3%.
Why: the numbers show the operating margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Polibeli Group Ltd posted a net loss of $0.01 B in the Dec 24 quarter. The full FY25 year was a loss of $0.01 B. That loss is 50.0% of the quarter's revenue.
Dec 24 profit was $−0.0 B, null year on year. On the full year, FY25 printed $−0.0 B (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Polibeli Group Ltd's cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $−0.0 B of operating cash against $−0.0 B of profit. After $0.0 B of capital spending, $−0.0 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY25: operating cash of $−0.0 B against reported profit of $−0.0 B, leaving free cash of $−0.0 B after $0.0 B of capital spending.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Polibeli Group Ltd does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Polibeli Group Ltd earns a ROE of 20% in FY25. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is −33.3% net margin on 1.50× asset turns.
FY25 ROE is 20%.
Why the return is what it is — the wiring (FY25): −33.3% net margin × 1.50× asset turns × −0.40× balance-sheet leverage ≈ 20.0% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
Dividend
Polibeli Group Ltd pays no dividend. Across the last 4 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Polibeli Group Ltd does not currently pay a dividend. Across the last 4 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
A borrowings history is not in our numbers for this stock.
A borrowings history is not in our numbers for this stock, so this section says that plainly rather than working around it.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
2.9% of Polibeli Group Ltd's tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 0.4 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 2.9% of the float is sold short, and at typical trading volumes it would take about 0.4 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Polibeli Group Ltd: the Z-score reads 12.44. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 12.44 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 12.44.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Macy's, Inc.M | 51.8/100Mixed-positive evidence82% evidence | BREAKING OUT | 10.4/35 Revenue -0.3% · PAT -22.6% · OPM change 0.3 pp 95% evidence | 6.4/25 ROCE 1% · OPM 2.3% 76% evidence | 15.0/20 P/E 8.1× · PEG 0.36 50% evidence | 20.0/20 RS sector 17.9% · RS bench 16% · 1Y 117%10 of 12 weeks ahead 100% evidence |
| Exact sum: 10.4 + 6.4 + 15 + 20 = 51.8 · Decision use: Price leads the evidence: RS versus the benchmark is 16%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 2Kohl's CorporationKSS | 47.7/100Mixed-negative evidence64% evidence | BREAKING OUT | 12.4/35 Revenue -3.8% · PAT 100% · OPM change -0.4 pp 71% evidence | 5.3/25 ROCE 0.4% · OPM 1.5% 76% evidence | 10.0/20 P/E 6.2× · PEG — 0% evidence | 20.0/20 RS sector 9.7% · RS bench 7% · 1Y 80.8%9 of 12 weeks ahead 100% evidence |
| Exact sum: 12.4 + 5.3 + 10 + 20 = 47.7 · Decision use: Price leads the evidence: RS versus the benchmark is 7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 3Dillard's, Inc.DDS | 38.9/100Mixed-negative evidence82% evidence | TURNING | 14.9/35 Revenue 0.6% · PAT 14% · OPM change 0.2 pp 95% evidence | 9.2/25 ROCE 8.1% · OPM 14.3% 76% evidence | 14.5/20 P/E 13.4× · PEG 0.83 50% evidence | 0.3/20 RS sector -6.3% · RS bench -7.7% · 1Y 31.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 14.9 + 9.2 + 14.5 + 0.3 = 38.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 4Polibeli Group Ltdthis pagePLBL | 34.6/100Thin evidence · provisional33% evidence | ASLEEP | 17.8/35 Revenue — · PAT — · OPM change — 3% evidence | 6.8/25 ROCE 0% · OPM — 46% evidence | 10.0/20 P/E — · PEG — 0% evidence | 0.0/20 RS sector -36.9% · RS bench -38.1% · 1Y -43.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17.8 + 6.8 + 10 + 0 = 34.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Polibeli Group Ltd's stock price today?
Polibeli Group Ltd trades at $6.0, −40.5% over the past year. The company is valued at $2.0 B. The stock sits at 9% of its 52-week range of $5–$12, −28.0% versus its 200-day average. On the tape, the price is in a downtrend, 5 weeks in. — as of 5 August 2026.
What were Polibeli Group Ltd's latest quarterly results?
Polibeli Group Ltd reported revenue of $0.0 B and a net loss of $0.0 B for the Dec 24 quarter. Earnings per share were $−0.02. The operating margin was 0.0%, 0.0 pp higher than a year earlier. — as of 5 August 2026.
What is Polibeli Group Ltd's revenue?
Polibeli Group Ltd reported revenue of $0.0 B in the Dec 24 quarter, +100.0% year on year. For the full FY25 fiscal year, revenue was $0.0 B (+0.0%). Over the last 3 years revenue compounded at 0.0% a year. — as of 5 August 2026.
What is Polibeli Group Ltd's profit?
Polibeli Group Ltd earned $−0.0 B of net profit in the Dec 24 quarter. Full-year FY25 profit was $−0.0 B. The operating margin ran 0.0% in the latest quarter. — as of 5 August 2026.
What is Polibeli Group Ltd's market cap?
Polibeli Group Ltd's market capitalisation is $2.0 B at a stock price of $6.0. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does Polibeli Group Ltd pay a dividend?
No — Polibeli Group Ltd has declared no dividend per share in any of its last 4 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
How is Polibeli Group Ltd performing?
Polibeli Group Ltd is in a downtrend, 5 weeks in. Against the S&P 500 it has been behind on a trailing-13-week view for 2 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
Is Polibeli Group Ltd in an uptrend?
No — the price is in a downtrend (week 5 of stage 4), trading −28.0% versus its 200-day average and at 9% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Polibeli Group Ltd beating the market?
Not lately — on a trailing-13-week view Polibeli Group Ltd is currently behind the S&P 500 (2 weeks and counting; last ahead the week of 2026-07-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 2.0 years the stock moved −40% against the S&P 500's +45% — behind the index over the full window. — as of 5 August 2026.
Will Polibeli Group Ltd's stock price go up?
This page publishes no price forecast for Polibeli Group Ltd. What it measures instead: the stock price is $6.0, the price is in a downtrend 5 weeks in. Direction is not something this site claims to know. — as of 5 August 2026.
Is the market betting against Polibeli Group Ltd?
Somewhat — short interest is 2.9% of Polibeli Group Ltd's tradable float, about 0.4 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
What is Polibeli Group Ltd's capex?
Polibeli Group Ltd spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 5 August 2026.
What is Polibeli Group Ltd's cash flow?
Polibeli Group Ltd generated $−0.0 B of operating cash flow in FY25 and $−0.0 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $−0.0 B, so operating cash ran ahead of profit. — as of 5 August 2026.
How financially safe is Polibeli Group Ltd?
On the balance sheet, the Z-score reads 12.44 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.
Where is Polibeli Group Ltd in its business cycle?
Polibeli Group Ltd's FY25 operating margin was −33.3%, against a 4-year band of −50.0%–−33.3%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 0.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Polibeli Group Ltd story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Polibeli Group Ltd a stock worth studying right now?
This is not investment advice. The machine read: Polibeli Group Ltd's balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup. The sharpest open question: whether the business can earn its way back to positive equity before dilution or restructuring gets there first. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.